Aalo Atomics did something on July 4, 2026 that no American nuclear startup of its generation had done: it achieved criticality — a self-sustaining nuclear chain reaction — in its Aalo-X test reactor at Idaho National Laboratory, hitting the deadline set by the federal Reactor Pilot Program to the day. For a company founded in 2023, going from incorporation to a critical reactor in roughly three years is the fastest such timeline in modern U.S. nuclear history.
The Austin-based company, led by co-founder and CEO Matt Loszak, builds “extra modular reactors” (XMRs) — factory-produced, sodium-cooled 10 MWe units — and packages five of them into the Aalo Pod, a 50 MWe plant purpose-built for AI data centers, designed to scale to gigawatts and co-locate directly with compute. Its first experimental data-center pairing is planned alongside the Aalo-X site.
Funding to date: a $6 million seed (2023), a $30 million Series A (2024), and a $100 million Series B announced in August 2025, led by Valor Equity Partners with participation from Fine Structure Ventures, Hitachi Ventures, NRG Energy, Tishman Speyer, and others — more than $136 million raised in total. No post-criticality round has been announced at the time of writing; given how sector peers re-priced after far smaller milestones, the next mark is the open question.
Can you buy Aalo Atomics stock?
Not on any exchange — Aalo is private, with no ticker. Accredited investors get exposure through:
- Direct secondary purchases — buying outstanding shares from an existing shareholder, subject to company transfer restrictions and rights of first refusal.
- Special purpose vehicles (SPVs) — pooled vehicles holding Aalo shares at smaller minimums than a direct block requires.
There is no public-proxy route; the cap table is venture and strategic capital.
Why the criticality milestone matters for pricing
Nuclear startups have historically been valued on paper designs and regulatory theory. A reactor that has actually gone critical — designed, built, fueled, and operated by the company at a national laboratory, on a federally mandated schedule — collapses a large share of the technical risk that keeps generalist capital out of the sector. Comparables re-priced on less: Radiant reached a $1.8 billion+ valuation before its first reactor test; Oklo trades publicly at a multiple of that without a commercial unit operating.
The counterweights:
- Criticality in a test reactor is not commercial operation. Licensing a commercial Aalo Pod, building the fuel supply chain, and delivering power to a paying customer remain ahead, each with its own timeline risk.
- At roughly $136 million raised, Aalo will need substantially more capital to build factories and first commercial plants — dilution between here and commercial scale is certain.
- The data-center-power thesis is crowded: Radiant, Oklo, Antares, and the restart-and-SMR programs of the majors all chase the same buyers.
For secondary buyers, that cuts both ways: an earlier-stage entry than Radiant or Oklo, at a fraction of their marks, against proportionally higher execution risk.
How access actually works
Aalo secondaries trade through brokers and SPV syndicators, typically with minimums from $100,000 upward. Because the company is private and early, expect:
- Very thin supply. A young cap table of committed funds and founders produces few natural sellers; blocks are rare and small.
- Transfer restrictions. Aalo can block or delay transfers; trades typically settle through existing SPVs.
- Milestone-gapped pricing. Post-criticality, asks have moved; the absence of a fresh priced round means secondary pricing is negotiated, not anchored.
At the time of writing, we have visibility into live Aalo Atomics secondary supply, including allocations accepting indications from accredited investors. Terms, pricing, and structure are available on request to qualified investors.
Is Aalo Atomics worth the risk?
The bull case: the fastest-executing nuclear startup in America, a critical reactor built on schedule, a product designed for the single most urgent energy buyer (AI data centers), Valor and Hitachi on the cap table, and an entry valuation far below sector leaders. The bear case: years and hundreds of millions of dollars between a test reactor and commercial revenue, certain dilution, licensing risk, fuel-supply dependency, crowded competition, and the standard private-market risks — illiquidity, limited information, and a long hold before any exit.
This is a concentrated, illiquid, early-stage position sized for the portion of a portfolio that can go to zero — more so than most names we cover.